Results 121 to 130 of about 33,112 (265)

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29‐02, a novel aqueous nasal spray [PDF]

, 2012
Hartmut Derendorf, Ullrich Munzel, U. Petzold, Joachim Maus, Hermann Mascher, Róbert Hermann, Jean Bousquet   +6 more
openalex   +1 more source

PRP10: PREDICTING THE BENEFIT OF OPTIMIZING SEVERE ASTHMA MANAGEMENT IN A MANAGED CARE SETTING:A COST-BENEFIT ANALYSIS COMPARING THE COMBINATION OF FLUTICASONE PROPIONATE AND SALMETEROL (FPS) AND ZAFIRLUKAST

, 2003
A Joglekar, Chih-Chung Chao, P Kadison
openalex   +1 more source

Cost-effectiveness of fluticasone propionate/salmeterol (500/50μg) in the treatment of COPD [PDF]

, 2008
Stephanie Earnshaw, Michele Wilson, Anand A. Dalal, Mike Chambers, Priti Jhingran, Richard H. Stanford, Douglas W. Mapel   +6 more
openalex   +1 more source

Serum cortisol as a systemic marker in the long-term treatment with fluticasone propionate (FP) in recurrent airways obstruction (RAO) aged horses.

Revista Científica, 2014
 This is the first fluticasone propianato (FP) long-term study in Recurrent Airways Obstruction (RAO)-aged horses (Equus ferus caballus) that compare Fluticasone Propionate (FP) treatment regimens, as well as FP treatment vs. environmental control, over
Trohadio Tomas Muñoz Díaz, Danilo Franco Jiménez   +1 more
doaj  

Additional file 1: of Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population

, 2017
Leif Bjermer, Job F. M. van Boven, Madlaina Costa‐Scharplatz, Dorothy L. Keininger, F Gutzwiller, Karin Lisspers, R Mahon, Petter Olsson, Nicolás Roche   +8 more
openalex   +1 more source

Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older [PDF]

, 2017
Gordon Raphael, Gloria Yiu, Anat Sakov, Siyu Liu, Cynthia Caracta   +4 more
openalex   +1 more source

Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19 [PDF]

, 2023
David R. Boulware, Christopher J. Lindsell, Thomas G. Stewart, Adrian F. Hernandez, Sean P. Collins, Matthew W. McCarthy, Dushyantha Jayaweera, Nina Gentile, Mario Castro, Mark Sulkowski, Kathleen M. McTigue, G. Michael Felker, Adit A. Ginde, Sarah E. Dunsmore, Stacey J. Adam, Allison DeLong, George J. Hanna, April Remaly, Florence Thicklin, Rhonda Wilder, Sybil Wilson, Elizabeth Shenkman, Susanna Naggie   +22 more
openalex   +1 more source

Systematic review on inhaled corticosteroid monotherapy and its efficacy and safety in longterm treatment of patients with chronic obstructive pulmonary disease (COPD) [PDF]

--chronic obstructive pulmonary disease,COPD,corticosteroids,systematic review,chronisch obstruktive Lungenerkrankung,COPD,Kortikosteroid,systematischer ...
Buchberger, Barbara, Kossmann, Beate, Neumann, Anja, Niebuhr, Dea, Wasem, Jürgen   +4 more
core  

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study

International Journal of COPD, 2017
Rupert Jones,1 Jessica Martin,2 Vicky Thomas,3 Derek Skinner,4 Jonathan Marshall,5 Martina Stagno d’Alcontres,2 David Price2,6 1Clinical Trials and Health Research, Institute of Translational and Stratified Medicine, Plymouth University Peninsula ...
Jones R, Martin J, Thomas V, Skinner D, Marshall J, Stagno d'Alcontres M, Price D   +6 more
doaj  

The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma

, 1999
J. H. Heinig, Louis‐Philippe Boulet, L. Croonenborghs, Marius J. Möllers   +3 more
openalex   +1 more source